Dosimetric comparison between intensity-modulated radiotherapy and RapidArc with single arc and dual arc for malignant glioma involving the parietal lobe

  • Authors:
    • Jun Yuan
    • Mingjun Lei
    • Zhen Yang
    • Jun Fu
    • Lei Huo
    • Jidong Hong
  • View Affiliations

  • Published online on: April 22, 2016     https://doi.org/10.3892/mco.2016.872
  • Pages: 181-188
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to evaluate the difference in treatment plan quality, monitor units (MUs) per fraction and dosimetric parameters between IMRT (intensity-modulated radiotherapy) and RapidArc with single arc (RA1) and dual arc (RA2) for malignant glioma involving the parietal lobe. Treatment plans for IMRT and RA1 and RA2 were prepared for 10 patients with malignant gliomas involving the parietal lobe. The Wilcoxon matched‑pair signed‑rank test was used to compare the plan quality, monitor units and dosimetric parameters between IMRT and RA1 and RA2 through dose‑volume histograms. Dnear‑max (D2%) to the left lens, right lens and left optical nerve in RA1 were less compared with those in IMRT; D2% to the right lens and right optic nerve in RA2 were less compared with those in IMRT. D2% to the optic chiasma in RA2 was small compared with that in RA1. The median dose (D50%) to the right lens and right optic nerve in RA1 and RA2 was less compared with the identical parameters in IMRT, and D50% to the brain stem in RA2 was less compared with that in RA1. The volume receiving at least 45 Gy (V45) or V50 in normal brain tissue (whole brain minus the planning target volume 2; B‑P) in RA1 was less compared with that in IMRT. V30, V35, V40, V45, or V50 in B‑P in RA2 was less compared with that in IMRT. The MUs per fraction in RA1 and RA2 were significantly less compared with those in IMRT. All differences with a P‑value<0.05 were considered to be significantly different. In conclusion, RA1 and RA2 markedly reduced the MUs per fraction, and spared partial organs at risk and B-P compared with IMRT.
View Figures
View References

Related Articles

Journal Cover

July 2016
Volume 5 Issue 1

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Yuan, J., Lei, M., Yang, Z., Fu, J., Huo, L., & Hong, J. (2016). Dosimetric comparison between intensity-modulated radiotherapy and RapidArc with single arc and dual arc for malignant glioma involving the parietal lobe. Molecular and Clinical Oncology, 5, 181-188. https://doi.org/10.3892/mco.2016.872
MLA
Yuan, J., Lei, M., Yang, Z., Fu, J., Huo, L., Hong, J."Dosimetric comparison between intensity-modulated radiotherapy and RapidArc with single arc and dual arc for malignant glioma involving the parietal lobe". Molecular and Clinical Oncology 5.1 (2016): 181-188.
Chicago
Yuan, J., Lei, M., Yang, Z., Fu, J., Huo, L., Hong, J."Dosimetric comparison between intensity-modulated radiotherapy and RapidArc with single arc and dual arc for malignant glioma involving the parietal lobe". Molecular and Clinical Oncology 5, no. 1 (2016): 181-188. https://doi.org/10.3892/mco.2016.872